Equity
Share-Based Payment - Unrecognized Cost of Nonvested Awards
Guardant Health Share-Based Payment - Unrecognized Cost of Nonvested Awards decreased by 31.6% to $25.6M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 47.5%, from $48.8M to $25.6M.
Analysis
StatementBalance Sheet Statement
SectionEquity
First reportedQ4 2018
Last reportedQ1 2026May 7, 2026
Metric ID:
share_based_payment_unrecognized_costHistorical Data
15 periods
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $19.7M | $22.7M | $27.9M | $32.7M | $32.9M | $39.7M | $39.6M | $38.9M | $37M | $34.2M | $29.3M | $48.8M | $43.7M | $37.4M | $25.6M |
| QoQ Change | — | +15.2% | +22.9% | +17.2% | +0.6% | +20.7% | -0.3% | -1.8% | -4.9% | -7.6% | -14.3% | +66.6% | -10.5% | -14.4% | -31.6% |
| YoY Change | — | — | — | +66.0% | +44.9% | +42.3% | +21.1% | +18.2% | -6.8% | -13.6% | -24.7% | +31.9% | +27.8% | +27.6% | -47.5% |
Range$19.7M – $48.8M
CAGR+7.8%
Avg YoY Growth+15.6%
Median YoY Growth+24.4%
Current Streak3 quarters decline
Share-Based Payment - Unrecognized Cost of Nonvested Awards at Other Companies
Frequently Asked Questions
- What is Guardant Health's share-based payment - unrecognized cost of nonvested awards?
- Guardant Health (GH) reported share-based payment - unrecognized cost of nonvested awards of $25.6M in Q1 2026.
- How has Guardant Health's share-based payment - unrecognized cost of nonvested awards changed year-over-year?
- Guardant Health's share-based payment - unrecognized cost of nonvested awards decreased by 47.5% year-over-year, from $48.8M to $25.6M.